Investment Summary

LabCorp Invests In Cofactor Genomics

On December 15, 2025, LabCorp invested in life science company Cofactor Genomics

Investment Highlights
  • This is LabCorp’s 22nd transaction in the Life Science sector.
  • This is LabCorp’s 45th transaction in the United States.
  • This is LabCorp’s 1st transaction in Missouri.

Investment Summary

Date 2025-12-15
Target Cofactor Genomics
Sector Life Science
Investor(s) LabCorp
Deal Type Stake Purchase

Target

Cofactor Genomics

St. Louis, Missouri, United States
Cofactor Genomics is a biotechnology company that develops a platform based on RNA that enables early detection and diagnosis of a disease. Cofactor Genomics is based in St. Louis, Missouri.

Search 214,877 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

LabCorp

Burlington, North Carolina, United States

Category Company
Founded 1995
Sector Test/Measurement Equipment
Employees67,000
Revenue 13.0B USD (2024)
DESCRIPTION
LabCorp's corporate headquarters in downtown Burlington, North Carolina.
LabCorp's corporate headquarters in downtown Burlington, North Carolina.

LabCorp of America Holdings is a provider of medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. LabCorp was founded in 1995 and is based in Burlington, North Carolina.


DEAL STATS #
Overall 47 of 47
Sector: Life Science M&A 22 of 22
Type: Stake Purchase M&A Deals 1 of 1
State: Missouri M&A 1 of 1
Country: United States M&A 45 of 45
Year: 2025 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2025-07-22 Community Health Systems - Ambulatory Outreach Laboratory Assets

Franklin, Tennessee, United States

Community Health Systems' Ambulatory Outreach Laboratory Assets

Buy $195M